334.5 EUR
5
1.47%
Last update Dec 16, 4:00 PM CET
Main market
Day range
329.70001
334.5
Previous close
339.5
Open
329.89999
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
334.50
5
1.47%

Financials

Cash flow

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Operating activities 206.3M 111.1M -123.9M -103.5M
Net income 214.0M -56.5M -49.0M -71.4M
Depreciation 11.8M 11.9M 12.3M -17.5M
Deferred taxes 4.8M 8.3M 8.2M
StockBased compensation 92.2M 95.2M 48.3M 78.1M
Other non cash items 40.3M 15.3M 13.3M 24.3M
Accounts receivable -340.9M -116.7M -6.3M -50.7M
Accounts payable 190.5M 155.3M -132.8M -52.9M
Other assets liabilities -6.4M -1.6M -18.0M -13.4M
Investing activities 429.0M -120.5M 97.0M -45.1M
Capital expenditures -10.4M -12.2M -7.6M -7.8M
Net intangibles
Net acquisitions
Purchase of investments -177.3M -391.8M -342.4M -414.9M
Sale of investments 616.7M 283.4M 447.0M 377.7M
Other investing activity -99.7K
Financing activities -29.4M -23.4M -4.5M -4.5M
Long term debt issuance
Long term debt payments
Short term debt issuance
Common stock issuance
Common stock repurchase
Common dividends
Other financing charges -29.4M -23.4M -4.5M -4.5M
End cash position 1.3B 951.3M 871.5M 825.8M
Income tax paid 1.1M -1.6M 2.5M
Interest paid 20.4M 12.4M 57.1M 10.5M
Free cash flow 266.8M 118.9M -108.5M -88.5M
Access the full /cash_flow historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 21 minutes

17:38
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).